Troponin T helps physicians triage MI patients
This article was originally published in Clinica
Executive Summary
Boehringer Mannheim's troponin T test for heart muscle damage can help emergency room physicians decide how to treat heart attack patients, according to data from the 15,000-patient GUSTO III study. The trial was designed to compare a new clot-dissolving drug made by Boehringer Mannheim with Genentech's t-PA, but also included an evaluation of the rapid bedside troponin-T test to decide whether it could help stratify the patients into high and low risk groups.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.